ATE552005T1 - Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend - Google Patents

Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend

Info

Publication number
ATE552005T1
ATE552005T1 AT06020126T AT06020126T ATE552005T1 AT E552005 T1 ATE552005 T1 AT E552005T1 AT 06020126 T AT06020126 T AT 06020126T AT 06020126 T AT06020126 T AT 06020126T AT E552005 T1 ATE552005 T1 AT E552005T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
active component
containing hyaluronan
hyaluronan
Prior art date
Application number
AT06020126T
Other languages
English (en)
Inventor
Akira Asari
Hiroko Yamanokuchi
Tadahiko Kato
Original Assignee
Glycoscience Lab Inc
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2005277918A external-priority patent/JP2007084509A/ja
Priority claimed from JP2005297991A external-priority patent/JP2007106688A/ja
Priority claimed from JP2005348017A external-priority patent/JP2007153761A/ja
Application filed by Glycoscience Lab Inc, Shiseido Co Ltd filed Critical Glycoscience Lab Inc
Application granted granted Critical
Publication of ATE552005T1 publication Critical patent/ATE552005T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT06020126T 2005-09-26 2006-09-26 Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend ATE552005T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005277918A JP2007084509A (ja) 2005-09-26 2005-09-26 細胞賦活剤
JP2005297991A JP2007106688A (ja) 2005-10-12 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤
JP2005348017A JP2007153761A (ja) 2005-12-01 2005-12-01 シナプス伝達促進剤及びシナプス保護剤

Publications (1)

Publication Number Publication Date
ATE552005T1 true ATE552005T1 (de) 2012-04-15

Family

ID=37667620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06020126T ATE552005T1 (de) 2005-09-26 2006-09-26 Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend

Country Status (7)

Country Link
EP (1) EP1767211B1 (de)
AR (1) AR056091A1 (de)
AT (1) ATE552005T1 (de)
BR (1) BRMU8603015U (de)
CA (1) CA2560844C (de)
NO (1) NO20064337L (de)
RU (1) RU2342148C2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008068854A1 (ja) 2006-12-05 2008-06-12 Glycoscience Laboratories, Inc. 変形性関節症の治療剤
JP5117110B2 (ja) * 2007-05-28 2013-01-09 生化学工業株式会社 Ｉ型アレルギー疾患治療剤
EP2818172A4 (de) * 2012-02-22 2016-02-17 Hyaluronan Res Inst Inc Tlr4-mittel, gewebehomöostatikum, hepatozytenwachstumsfaktorinduktor, gewebereparierendes mittel und sirtuininduktor mit hyaluronsäurefragmenten als wirkstoffe davon
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
EP4085905B1 (de) * 2021-05-07 2024-02-21 TRB Chemedica AG Hyaluronsäure zur verwendung bei der vorbeugung oder behandlung neurologischer dysfunktionen von nerven oder nervenzellen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013641A (en) * 1995-09-28 2000-01-11 Sangstat Medical Corporation Use of hyaluronic acid as an immunosuppressant
JP4195107B2 (ja) * 1996-02-16 2008-12-10 生化学工業株式会社 ストレス蛋白質発現増強剤
IT1309588B1 (it) * 1999-03-05 2002-01-24 Altergon Sa Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.
JP2003089647A (ja) * 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
US7507723B2 (en) * 2000-07-07 2009-03-24 Seikagaku Corporation Hyaluronic acid oligosaccharide fractions and drugs containing the same
US6537968B1 (en) * 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
US7060691B2 (en) * 2002-10-10 2006-06-13 Giuseppe Petrigni Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen

Also Published As

Publication number Publication date
RU2006134169A (ru) 2008-03-27
NO20064337L (no) 2007-03-27
RU2342148C2 (ru) 2008-12-27
AR056091A1 (es) 2007-09-19
EP1767211A1 (de) 2007-03-28
EP1767211B1 (de) 2012-04-04
BRMU8603015U (pt) 2007-12-11
CA2560844A1 (en) 2007-03-26
CA2560844C (en) 2011-05-17

Similar Documents

Publication Publication Date Title
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
RU2398586C3 (ru) Фармацевтическая композиция
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
NO20075628L (no) Farmasøytiske formuleringer
SMP200800041B (it) Derivati di pirimidinil-aril-urea attivi come-fgf-inibitori
BRPI0715712A2 (pt) Composição farmacêutica
DK1962873T3 (da) Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0511900A (pt) composições farmacêuticas
BRPI0719393A2 (pt) Composição farmacêutica
DK1876897T3 (da) Aktivstofkombinationer
ATE532788T1 (de) Pharmazeutische verbindungen
ATE493119T1 (de) Pharmazeutische zusammensetzung
DK1957073T3 (da) Lægemiddel
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
ATE453384T1 (de) Neue dosierformulierung
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0719398A2 (pt) Composição farmacêutica.
BRPI0720234A2 (pt) Composição farmacêutica
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0810399A2 (pt) Composto, composição farmacêutica que o contém e uso do mesmo
ITMI20051630A1 (it) Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi